iCAD, Inc. Introduces MRI Products To Help Improve Detection And Diagnosis Of Breast Cancer

Medical News Today -- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, will unveil two new MRI products at the 7th Annual Symposium on Advances in Breast MRI in Las Vegas, from October 16-18: SpectraLook™, innovative kinetics technology integrated into iCAD's image analysis solutions for breast and prostate MRI studies; and CADvue™, image review and analysis software designed to improve the analysis workflow, interventional planning and reporting of breast MR results.